Notice June 21, 2023

AttnKare-D to Conduct Clinical Trials with the University of Nebraska Medical Center in the U.S.

#Clinical Trial#UNMC#AttnKare
AttnKare-D to Conduct Clinical Trials with the University of Nebraska Medical Center in the U.S.

Hippo T&C’s ADHD diagnostic digital therapeutic, AttnKare-D, will undergo clinical trials conducted by Dr. Soonjo Hwang’s research team at the University of Nebraska Medical Center.

Back to List